Human BioSystems signs non-binding LOI with San West
Under the terms of the non-binding letter of intent (LOI), San West would acquire 85% of the outstanding common stock of Human BioSystems, pursuant to the contemplated merger
XtalPi has entered a strategic partnership valued at more than $400m with an international biopharmaceutical company to develop oral small-molecule therapeutics targeting a G protein-coupled receptor (GPCR).